MediFind
Condition

Lymphofollicular Hyperplasia

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 40
  • Start Date: February 4, 2019
A Phase 1/2 Study of Pembrolizumab Plus Pralatrexate for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphomas
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 86
  • Start Date: April 1, 2017
Efficacy and Safety of Two Glucocorticoid Regimens in the Treatment of Sarcoidosis: a Randomized Controlled Trial